Sofinnova Investments’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,411,769
Closed -$33.3M 86
2023
Q4
$33.3M Buy
+1,411,769
New +$33.3M 1.87% 15
2023
Q3
Hold
0
65